Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)
Clinical trial NCT00237484 · COMPLETED
Trial details
- NCT number
- NCT00237484
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-18
- Primary completion
- 2011-06-30
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.